A major sub-group of the National Haemophilia Council will be the product selection and monitoring group. A key task of this group will be to ensure all decisions in relation to the selection, procurement, distribution and monitoring of products used in the treatment of haemophilia adhere to the highest standards. The Irish Haemophilia Society will play a pivotal role on this committee, with the National Centre for Hereditary Coagulation Disorders, the Irish Blood Transfusion Service, health boards, and other relevant interests. An ad hoc group is already in place for over a year now and shortly its membership will be expanded to involve key professionals with an expertise in various aspects of haemophilia treatment.